US Proposal To Pay Pharmacists For Drug Services

14 July 1996

Proposed US legislation would, for the first time, pay pharmacists for the drug care services they provide to Medicare beneficiaries.

Legislation introduced by Representative Frank Pallone before the July 4 break would pay druggists for certain critical services to Medicare patients, including consultation with a physician that results in changes in a patient's drug regimen, counseling to improve patient compliance with a regimen prescribed for certain high-risk diseases, and administration of flu and other vaccines where authorized by state law. The Secretary of Health and Human Services would be required to develop a fee schedule for pharmaceutical care services, based on time required for services, level of risk of particular drugs and differences in the health statute of patients receiving services.

Inappropriate Drug Use "Costs $ Billions Each Year" The American Pharmaceutical Association has endorsed the legislation, noting that inappropriate use of prescription drugs, particularly among older Americans, is well documented. Recent government reports and articles in medical journals have shown that these problems have harmed tens of thousands of patients, and cost Americans billions of dollars needlessly every year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight